Hot Biotechs (fka HOTBIO)

[alexed]

Have a look at MLHP,can not get a quote?


April 25, 2001 17:55 International Day for Malaria: Millenia Hope's MALAREX-TM Goes on the Market -- Anti-Malarial Drug to be Introduced in West AfricaMONTREAL--(BUSINESS WIRE)--April 25, 2001--Millenia Hope Inc (OTCBB:MLHP), a young biotech corporation, announced that MALAREX(TM), its flagship anti-malarial drug, will be marketed in West Africa, beginning with Burkina Faso. Following its initial successful introduction, the company expects in the near future, to market its product in the other 17 countries that comprise West Africa, a region highly prone to the scourge of malaria. Millenia expects to sell 5 million treatments of MALAREX(TM) this year. "This is very exciting news for the Quebec based company, but even more so for the developing nations of Africa and Asia. They are desperate for a new anti-malarial drug that is not affected by the parasite resistance so common in the drugs currently on the market," said Dominique Morisot, president and CEO of Millenia Hope. Malaria is a disease that affects up to 500 million people annually. It causes in excess of 2.5 million deaths including over 1 million young children. MALAREX(TM), an all natural drug with no harmful side effects, has already proven to be effective against the parasites that cause this horrific disease. About Millenia Hope Millenia Hope is in the business of developing innovative treatments and quality medication products that will lead to healthier lives. Our people are committed to research and development to meet unmet medical needs globally and to bring hope through healthcare solutions. Safe Harbour Statement Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forwarding-looking statements". Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, service offerings and markets. CONTACT: Millenia Hope Inc. Dominique Morisot, 514/846-5757 [e-mail]